A Phase II Study of Combination Therapy With Paclitaxel, Carboplatin and Megesterol Acetate [megestrol] for the Management of Advanced Stage or Recurrent Carcinoma of the Endometrium.

Trial Profile

A Phase II Study of Combination Therapy With Paclitaxel, Carboplatin and Megesterol Acetate [megestrol] for the Management of Advanced Stage or Recurrent Carcinoma of the Endometrium.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2015

At a glance

  • Drugs Carboplatin (Primary) ; Megestrol (Primary) ; Paclitaxel (Primary)
  • Indications Endometrial cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Mar 2012 Actual patient number changed from 35 to 30 as reported by ClinicalTrials.gov.
    • 28 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Oct 2010 Planned end date changed from May 2010 to Oct 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top